The upregulation of PARK7 enhances tumor formation and the metastasis of pancreatic cancer and disrupts the extracellular matrix of the cancer cells by inducing the expression of the urokinase plasminogen activator by activating Src and ERK [33]. The gene discussed is PARK7; the disease is pancreatic neoplasm.